Attached files

file filename
EX-4.5 - COMMON STOCK PURCHASE WARRANT ISSUED TO ALEXANDER CAPITAL, L.P. - CYTRX CORPexh_4-5.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER, PURSUANT TO 15 U.S.C. SECTION 7241 - CYTRX CORPexh_31-2.htm
EX-23.1 - CONSENT OF BDO USA, LLP - CYTRX CORPexh_23-1.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER, PURSUANT TO 18 U.S.C. SECTION 1350 - CYTRX CORPexh_32-2.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER, PURSUANT TO 18 U.S.C. SECTION 1350 - CYTRX CORPexh_32-1.htm
EX-10.12 - FORM OF NON-QUALIFIED STOCK OPTION GRANT FOR EXECUTIVE OFFICERS - CYTRX CORPexh_10-12.htm
EX-10.26 - DR. DANIEL LEVITT EMPLOYMENT AGREEMENT DATED DECEMBER 31, 2015 - CYTRX CORPexh_10-26.htm
EX-10.29 - JOHN CALOZ EMPLOYMENT AGREEMENT DATED DECEMBER 31, 2015 - CYTRX CORPexh_10-29.htm
EX-10.14 - AMENDMENT NO. 1 TO STOCK OPTION AGREEMENTS OF DR. DANIEL LEVITT, DATED DEC. 31, 2015 - CYTRX CORPexh_10-14.htm
EX-32 - LETTER AGREEMENT WITH ALEXANDER CAPITAL LLP DATED FEB. 9, 2016 - CYTRX CORPexh_10-32.htm
EX-10.13 - FORM OF NON-QUALIFIED STOCK OPTION FOR GRANTS TO S. KRIEGSMAN AND DR. D. LEVITT - CYTRX CORPexh_10-13.htm
EX-10.15 - AMENDMENT NO. 1 TO STOCK OPTION AGREEMENTS (2000 PLAN) OF STEVEN. KRIEGSMAN, DATED MARCH 8, 2016 - CYTRX CORPexh_10-15.htm
EX-10.28 - SCOTT WIELAND EMPLOYMENT AGREEMENT DATED DECEMBER 31, 2015 - CYTRX CORPexh_10-28.htm
EX-10.30 - OLIVIA WARE EMPLOYMENT AGREEMENT DATED JANUARY 11, 2016 - CYTRX CORPexh_10-30.htm
EX-10.16 - AMENDMENT NO. 1 TO STOCK OPTION AGREEMENTS (2008 PLAN) OF STEVEN. KRIEGSMAN, DATED MARCH 8, 2016 - CYTRX CORPexh_10-16.htm
10-K - FORM 10-K ANNUAL REPORT FOR FISCAL YEAR ENDING 2015 DECEMBER 31 - CYTRX CORPform10-k_2015.htm
EX-10.27 - BENJAMIN LEVIN EMPLOYMENT AGREEMENT DATED DECEMBER 31, 2015 - CYTRX CORPexh_10-27.htm
EX-10.11 - FORM OF NON-QUALIFIED STOCK OPTION GRANT TO NON-EMPLOYEE DIRECTORS - CYTRX CORPexh_10-11.htm
EX-10.36 - STEVEN KRIEGSMAN THIRD AMENDMENT TO 4TH AMENDED AND RESTATED EMPLOYMENT AGREEMENT DATED MARCH 8, 2016 - CYTRX CORPexh_10-36.htm
Exhibit 31.1
 
CERTIFICATIONS

 
I, Steven A. Kriegsman, Chief Executive Officer of CytRx Corporation, certify that:
1.      I have reviewed this annual report on Form 10-K of CytRx Corporation;
2.      Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this annual report;
3.      Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
4.      The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)            Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
(b)            Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)            Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the periods covered by this report based on such evaluation; and
(d)            Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.      The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)            All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)            Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
  CYTRX CORPORATION  
       
Date: March 11, 2016
By:
/s/ STEVEN A. KRIEGSMAN  
    Steven A. Kriegsman  
    Chairman and Chief Executive Officer